The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived micro particles

Thrombosis and Haemostasis

Volumn 107, Issue 6, 2012, Pages 1044-1052

  Gerotziafas, Grigoris T ^a,b   van Dreden, Patrick ^c   Chaari, Mourad ^b   Galea, Vassiliki ^a,b   Khaterchi, Amir ^a,b   Lionnet, Francois ^b   Stankovic Stojanovic, Katice ^b   Blanc Brude, Olivier ^d   Woodhams, Barry ^c   Maier Redelsperger, Micheline ^b   Girot, Robert ^b   Hatmi, Mohamed ^a,e   Elalamy, Ismail ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL TENON   (France)

^c Research and Development   (France)

^d PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^e INSTITUT PASTEUR   (France)

Author keywords

Hydroxyurea; Micro particles; Sickle cell disease; Thrombin generation

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN; HEMOGLOBIN F; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYUREA; PHOSPHATIDYLSERINE; PHOSPHOLIPID; THROMBOMODULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE MICROPARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; MONOCYTE; NEUTROPHIL COUNT; PLATELET MICROPARTICLE; PRIORITY JOURNAL; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; STEADY STATE; THROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTE FREE PLASMA;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; HEMOGLOBINS; HUMANS; HYDROXYUREA; MALE; PARIS; PHOSPHATIDYLSERINES; THROMBIN; THROMBOMODULIN; THROMBOPHILIA; TIME FACTORS; YOUNG ADULT;

EID: 84861724304     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-10-0689     Document Type: Article

References (38)

1. Austin H, Key NS, Benson JM, et al. Sickle cell trait and the risk of venous throm-boembolism among blacks. Blood 2007; 110: 908-912.
2. Prengler M, Pavlakis SG, Prohovnik I, et al. Sickle cell disease: the neurological complications. Ann Neurol 2002; 51:543-552.
3. Ataga KI, Cappellini MD, Rachmilewitz EA. Betathalassaemia and sickle cell anaemia as paradigms of hypercoagulability. Br J Haematol 2007; 139: 3-13.
4. Au NH, Wong AY, Vickars L, et al. Two new examples of Hb St. Etienne [beta 92(F8)HisGln] in association with venous thrombosis. Hemoglobin 2009; 33:95-100.
5. Ataga KI. Hypercoagulability and thrombotic complications in hemolytic anemias. Haematologica 2009; 94: 1481-1484.
6. Hagger D, Wolff S, Owen J, et al. Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls. Blood Coagul Fibrinolysis 1995; 6: 93-99.
7. De Franceschi L, Cappellini MD, Olivieri O. Thrombosis and sickle cell disease. Semin Thromb Hemost 2011; 37: 226-236.
8. Kaul DK, Hebbel R P. Hypoxia/re oxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 2000; 106: 411-420.
9. Osarogiagbon UR, Choong S, Belcher JD, et al. Reperfusion injury pathophysiology in sickle transgenic mice. Blood 2000; 96: 314-320.
10. Gavins FN, Russell J, Senchenkova EL, et al. Mechanisms of enhanced thrombus formation in cerebral micro vessels of mice expressing hemoglobin-S. Blood 2011; 117: 4125-4133.
11. Proença-Ferreira R, Franco-Penteado CF, Traina F, et al. Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIb beta3-mediated ligand binding, diminished cAMP signaling and increased phosphodiesterase 3A activity. Br J Haematol 2010; 149: 280-288.
12. van Beers EJ, Schaap MC, Berckmans RJ, et al.; CURAMA study group. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009; 94: 1513-1519.
13. Allan D, Limbrick AR, Thomas P, et al. Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature 1982; 295: 612-613.
14. Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phos-pholipids asymmetry in blood cells. Blood 1997; 89: 1121-1132.
15. Setty BN, Kulkani S, Stuart MJ. Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood 2002; 99: 1564-1571.
16. Tait JF, Gibson D. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J Lab Clin Med 1994; 123: 741-748.
17. Stein PD, Beemath A, Meyers FA, et al. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med 2006; 119: 897.e7-11.
18. Hendrick AM. Auto-immune haemolytic anaemia - a high-risk disorder for thromboembolism? Hematology 2003; 8: 53-56.
19. Devaux PF, Zachowski A. Maintenance and consequences of membrane phos-pholipid asymmetry. Chem Phys Lipids 1994; 73: 107-120.
20. Fadok VA, Voelker DR, Campbell PA, et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207-2216.
21. Hebbel R P, Eaton JW, Balasingam M, et al. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest. 1982; 70: 1253-1259.
22. Setty BN, Rao AK, Stuart MJ. Thrombophilia in sickle cell disease: the red cell connection. Blood 2001; 98: 3228-3233.
23. Devaux PF. Static and dynamic lipid asymmetry in cell membranes. Biochemistry 1991; 30: 1163-1173.
24. Westerman M P, Green D, Gilman-Sachs A, et al. Coagulation changes in individual with sickle ceel trait. Am J Hematol. 2002; 69: 89-94.
25. Helley D, Girot R, Guillin MC, et al. Sickle cell disease: relation between procoagulant activ it y of red blood cells from different phenotypes and in vivo blood coag ulation activation. Br J Haematol 1997; 99: 268-272.
26. Setty BN, Kulkarni S, Rao AK, et al. Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation. Blood 2000; 96: 1119-1124.
27. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 2010; 376: 2018-2031.
28. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crisis in sickle cell anemia. Investigators of the Multi center study of Hydroxyurea in sickle cell anemia. N Engl J Med 1995; 332: 1317-1322.
29. Westerman M P, Cole ER, Wu K. The effect of spicules obtained from sickle red cells on clotting activity. Br J Haematol 1984; 56: 557-562.
30. Brummel-Ziedins KE, Orfeo T, Rosendaal FR, et al. Empirical and theoretical phenotypic discrimination. J Thromb Haemost 2009; 7 (Suppl 1): 181-186.
31. Freyssinet JM, Toti F. Formation of procoagulant micro particles and properties. Thromb Res 2010; 125 (Suppl 1): S46-48.
32. Piccin A, Murphy WG, Smith O P. Circulating micro particles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-171.
33. Ataga KI, Key NS. Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Prog 2007: 91-96.
34. Westerman M, Pizzey A, Hirschman J, et al. Microvesicles in haemoglobin-opathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol 2008; 142: 126-135.
35. Bridges KR, Barabino GD, Brugnara C, et al. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood 1996; 88: 4701-4710.
36. Covas TC, de Lucenas I, Vianna Bonini Palma P. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia. Haematologica 2004; 89: 273-280.
37. Setty BN, Kulkarni S, Dampier CD, et al. Fetal haemoglobin in sickle cell anemia: relationship to erythrocyte adhesion markers and adhesion. Blood 2001; 97: 2568-2573.
38. Hebbel R P, Boogaerts MA, Eaton JW, et al. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med 1980; 302: 992-995.